alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 By Notice dated May 19, 2008 and published in the 
                    **Federal Register**
                     on May 27, 2008 (73 FR 30418), AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug
ScheduleMarihuana (7360)
ITetrahydrocannabinols (7370)
IAmphetamine (1100)
IILisdexamfetamine (1205)
IIMethylphenidate (1724)
IIPentobarbital (2270)
IIHydrocodone (9193)
IIMeperidine (9230)
IIDextropropoxyphene, bulk (non-dosage form) (9273)
IIOxymorphone (9652)
IIFentanyl (9801)
II
 The company plans to manufacture bulk controlled substances for use in product development and for distribution to its customers. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol as a synthetic intermediate. This controlled substance will be further synthesized to bulk manufacture a synthetic THC (7370). No other activity for this drug code is authorized for this registration. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of AMRI Rensselaer, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated AMRI Rensselaer, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: September 22, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. E8-22876 Filed 9-26-08; 8:45 am] BILLING CODE 4410-09-P
[Federal Register Volume 73, Number 194 (Monday, October 6, 2008)]
[Notices]
[Pages 58247-58248]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-23479]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Children and Families


Office of Refugee Resettlement

AGENCY: Office of Refugee Resettlement, ACF, DHHS.

ACTION: Notice of a Noncompetitive Successor Award to California 
Department of Public Health.

-----------------------------------------------------------------------

    CFDA #: 93.576
    Legislative Authority: This Program is authorized by section 
412(b)(5) of the Immigration and Nationality Act (INA), as amended (8 
U.S.C. 1522(b)(5)), which

[[Page 58248]]

authorizes the Director to provide for medical screening and initial 
medical treatment.
    Amount of Award: There are three years remaining in the project The 
remaining funds to be awarded is $1,425,000.
    Project Period: July 1, 2006 through June 30, 2010.
SUMMARY: The purpose of the ORR award is to assist California in 
providing medical screenings in accordance with ORR guidance in State 
Letter 95-37, 11/21/95, and follow-up activities to newly arriving 
refugees for conditions of public health concern. California Senate 
Bill 162 established a new California Department of Public Health to 
take the place of the California Department of Health Services which 
ceased to exist. California requests that the funds be awarded to the 
new California Department of Public Health to carry out the remaining 
years of the project.

FOR FURTHER INFORMATION CONTACT: Further information regarding the 
request may be directed to Pam Green-Smith at 202-401-4531, 
<a href="/cdn-cgi/l/email-protection#641405090108054a031601010a17090d100c240507024a0c0c174a030b12"><span class="__cf_email__" data-cfemail="cebeafa3aba2afe0a9bcababa0bda3a7baa68eafada8e0a6a6bde0a9a1b8">[email protected]</span></a>.

    Date: September 30, 2008.
David H. Siegel,
Acting Director, Office of Refugee Resettlement.
 [FR Doc. E8-23479 Filed 10-3-08; 8:45 am]
BILLING CODE 4184-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>
 
                                                                      Exhibit 11

<TABLE>
<CAPTION>
                                                                    Nine Months Ended
                                                                      September 30,
                                                                    1997          1996
                                                                  (DOLLARS IN THOUSANDS)
<S>                                                              <C>             <C>
Primary net income per share:                                                    
     Net income.............................................     $   12,242    $   (1,082)
     Preferred stock dividend...............................            652             -
     Net income available to common shareholders............         11,590        (1,082)
     Average number of shares outstanding...................      7,570,000     4,923,784
     Net effect of dilutive stock options-based on                             
      treasury stock method using average market price......        312,555             -
     Total average shares...................................      7,882,555     4,923,784
     Primary net income per share...........................     $     1.47    $    (0.22)
                                                                               
Fully diluted net income per share:                                            
     Net income.............................................     $   12,242    $   (1,082)
     Preferred Stock dividend...............................            652           ---
     Net income available to common shareholders............         11,590        (1,082)
     Average number of shares outstanding...................      7,570,000     4,923,784
     Net effect of dilutive stock options-based on..........        662,281           ---
      treasury stock method using ending share price                           
     Total average shares...................................      8,232,281     4,923,784
     Fully diluted net income per share.....................          $1.41        $(0.22)
                                                                                    
</TABLE>

                                      22
Exhibit 99.3

 

| Reports on internal control |
|-----------------------------|

Management’s report on internal control over financial reporting

The management of BCE Inc. (BCE) is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is a process designed under the supervision of the President and Chief Executive Officer and the Executive Vice-President and Chief Financial Officer and effected by the Board of Directors, management and other personnel of BCE, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB).

Due to its inherent limitations, internal control over financial reporting may not prevent or detect misstatements on a timely basis. Also, projections of any evaluation of the effectiveness of internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management evaluated, under the supervision of and with the participation of the President and Chief Executive Officer and the Executive Vice-President and Chief Financial Officer, the effectiveness of our internal control over financial reporting as at December 31, 2016, based on the criteria established in *Internal Control – Integrated Framework (2013)*issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

Based on that evaluation, the President and Chief Executive Officer and the Executive Vice-President and Chief Financial Officer concluded that our internal control over financial reporting was effective as at December 31, 2016. There were no material weaknesses that have been identified by BCE’s management in internal control over financial reporting as at December 31, 2016.

Our internal control over financial reporting as at December 31, 2016 has been audited by Deloitte LLP, Independent Registered Public Accounting Firm, who also audited our consolidated financial statements for the year ended December 31, 2016. Deloitte LLP issued an unqualified opinion on the effectiveness of our internal control over financial reporting as at December 31, 2016.

(signed) George A. Cope
J

- S05036

- 20

NON - PRECEDENTIAL DECISION - SEE SUPERIOR COURT I.O.P. 65.37 COMMONWEALTH OF PENNSYLVANIA

v.

FREUD LABARRIERE

Appellant : : : : : : : : : IN THE SUPERIOR COURT OF

PENNSYLVANIA

No. 1392 MDA 2019 Appeal from the Judgment of Sentence Entered March 13, 2019 In the Court of Common Pleas of Lancaster County Criminal Division at

No(s): CP

- 36

- CR

- 0004555

- 2018

BEFORE: SHOGAN, J., KUNSELMAN, J., and MUSMANNO, J. CONCURRING MEMORANDUM BY SHOGAN, J.: FILED: MAY 13, 2020 I agree with the learned Majority that appellate counsel has failed to present for direct review an issue of arguable merit and that remand is required. The Majority frames the issue as: “Whether [Appell ant] knowingly refused breath testing, where the record does not reflect whether [Appellant] was informed of the [mandatory] criminal penalties.” Majority Memorandum at 6. As framed, the issue to be addressed on remand could be interpreted

as a non - wa i v a ble challenge to the legality of Appellant’s sentence, i.e. , the proper application of a mandatory minimum sentence. See Commonwealth v. Diamond , 945 A.2d 252, 256 (Pa. Super. 2008) (stating, generally, that a challenge to the application of a mandatory m inimum sentence is a non

waivable challenge to the legality of sentence).J

- S05036

- 20

- 2

-

However, t o the extent that the issue is interpreted as an evidentiary challenge pursuant to Birchfield v. North Dakota , ___ U.S. ___ , 136 S.Ct. 2160 (2016), I must observe that Ap pellant attempted to have a motion to suppress evidence presented to the trial court by trial counsel. N.T., 3/13/19, at 3

- 4. Without any indication as to the basis of the request to suppress, trial counsel refused Appellant’s request stating to the cour t: “We spoke about the issues with [Appellant] and let him know why it was a bad idea and that there were no issues to consider for suppression .” Id . at 4 (emphasis added). Hence, I write separately to further alert Appellant of the possibility of a challenge to the effective assistance of trial counsel, which must be presented in a timely PCRA petition. See Commonwealth v. Holmes , 79 A.3d 562, 576 (Pa. 2013) (reaffirming the general rule that “claims of ineffective assistance of counsel are to be deferred to PCRA review; trial courts should not entertain claims of ineffectiveness upon post

- verdict motions; and such claims should not be reviewed upon direct appeal”). Regardless, I agree with the M ajority that remand at this juncture is critical so that the issue may be properly developed and vital points in the record amplified. Judge Kunselman joins this Concurring Memorandum.
Release dates | Full version (300 KB PDF)Actions by the Board | Actions   under delegated authority  Applications and reports:Boston |New York |Philadelphia |Cleveland |Richmond |AtlantaChicago |St. Louis |Minneapolis |Kansas City |Dallas |San FranciscoDistrict: 1Federal Reserve Bank of: BostonFilings received during the week ending March 9, 2019FilerFiling TypeFiling ProposalEnd of Comment PeriodBANKNEWPORT                                                                                                             * BranchApplication by BankNewport, Newport, Rhode Island, to establish a branch at 1423 Hartford Avenue, Johnston, Rhode Island, pursuant to Section 208.6 of Regulation H.Newspaper: Not availableFederal Register: Not applicablePILGRIM BANK                                                                                                            * 18CAbington Bank, Abington, Massachusetts ('Abington') to merge with and into Pilgrim Bank, Cohasset, Massachusetts ('Pilgrim'), with Pilgrim as the surviving entity to be renamed 'Abington Bank'; and for the resulting institution to retain all of Abington's current offices; and to change the resulting institution's principal office from Cohasset, Massachusetts to Abington, Massachusetts; and for the three branch offices of Pilgrim Bank to be operated under the name 'Pilgrim Bank, a Division of Abington Bank.'Newspaper: Not availableFederal Register: Not applicable
IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLORADO

Magistrate Judge Michael J. Watanabe

Civil Action No. 11-cv-02414-PAB-MJW FTR - Courtroom A-502

Date: February 07, 2012 Courtroom Deputy, Ellen E. Miller

Parties

BOBBY BROWN,

Plaintiff(s),

Counsel

Jeffrey S. Vail

v.

A&E TELEVISION NETWORKS, LLC,

HYBRID FILMS, INC., and

D&D TELEVISION PRODUCTIONS, INC.,

Defendant(s).

Richard P. Holme

COURTROOM MINUTES / MINUTE ORDER

HEARING: TELEPHONIC MOTION HEARING

Court in session: 10:02 a.m.

Court calls case. Appearances of counsel.

The Court raises the Parties’ Joint Motion to Stay Discovery Pending Ruling on Defendants’

Motion to Dismiss for Improper Venue for discussion. Plaintiff’s position is clarified.

It is ORDERED: PARTIES’ JOINT MOTION TO STAY DISCOVERY PENDING RULING

ON DEFENDANTS’ MOTION TO DISMISS FOR IMPROPER VENUE

[Docket No. 25, filed January 25, 2012] is GRANTED for reasons as set

forth on the record.

Discovery in this case is STAYED until further order of the Court.

It is noted Defendants’ Motion to Dismiss for Improper Venue is fully briefed. If the motion is

denied, the Court will set a Status Conference to discuss further proceedings.

It is ORDERED: The TELEPHONIC STATUS CONFERENCE set FEBRUARY 29, 2012 

at 9:00 a.m. is VACATED.

HEARING CONCLUDES. Court in recess: 10:11 a.m. Total In-Court Time: 00:09

To order a transcript of this proceedings, contact Avery Wood Reports (303) 825-6119 or Toll Free 1-800-962-3345. 

Case 1:11-cv-02414-PAB-MJW Document 29 Filed 02/07/12 USDC Colorado Page 1 of 1
II 

110TH CONGRESS 

1ST SESSION S. 1161 

To amend title XVIII of the Social Security Act to authorize the expansion 

of medicare coverage of medical nutrition therapy services. 

IN THE SENATE OF THE UNITED STATES 

APRIL 19, 2007 

Mr. BINGAMAN (for himself, Mr. CRAIG, Mr. CONRAD, Mr. SCHUMER, and Ms. 

CANTWELL) introduced the following bill; which was read twice and referred to the Committee on Finance 

A BILL 

To amend title XVIII of the Social Security Act to authorize 

the expansion of medicare coverage of medical nutrition 

therapy services. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Medicare Medical Nu5 trition Therapy Act of 2007’’. 

mstockstill on PROD1PC66 with BILLS

2 

•S 1161 IS

1 SEC. 2. AUTHORIZING EXPANSION OF MEDICARE COV2 ERAGE OF MEDICAL NUTRITION THERAPY 

3 SERVICES. 

4 (a) AUTHORIZING EXPANDED ELIGIBLE POPU5 LATION.—Section 1861(s)(2)(V) of the Social Security 

6 Act (42 U.S.C. 1395x(s)(2)(V)) is amended— 

7 (1) by redesignating clauses (i) through (iii) as 

8 subclauses (I) through (III), respectively, and in9 denting each such clause an additional 2 ems; 

10 (2) by striking ‘‘in the case of a beneficiary 

11 with diabetes or a renal disease who—’’ and insert12 ing ‘‘in the case of a beneficiary— 

13 ‘‘(i) with diabetes or a renal disease 

14 who—’’; 

15 (3) by adding ‘‘or’’ at the end of subclause (III) 

16 of clause (i), as so redesignated; and 

17 (4) by adding at the end the following new 

18 clause: 

19 ‘‘(ii) who is not described in clause (i) but 

20 who has another disease, condition, or disorder 

21 for which the Secretary has made a national 

22 coverage determination (as defined in section 

23 1869(f)(1)(B)) for the coverage of such serv24 ices;’’. 

25 (b) COVERAGE OF SERVICES FURNISHED BY PHYSI26 CIANS.—Section 1861(vv)(1) of the Social Security Act 

mstockstill on PROD1PC66 with BILLS

3 

•S 1161 IS

1 (42 U.S.C. 1395x(vv)(1)) is amended by inserting ‘‘or 

2 which are furnished by a physician’’ before the period at 

3 the end. 

4 (c) NATIONAL COVERAGE DETERMINATION PROC5 ESS.—In making a national coverage determination de6 scribed in section 1861(s)(2)(V)(ii) of the Social Security 

7 Act, as added by subsection (a)(4), the Secretary of 

8 Health and Human Services, acting through the Adminis9 trator of the Centers for Medicare & Medicaid Services, 

10 shall— 

11 (1) consult with dietetic and nutrition profes12 sional organizations in determining appropriate pro13 tocols for coverage of medical nutrition therapy serv14 ices for individuals with different diseases, condi15 tions, and disorders; and 

16 (2) consider the degree to which medical nutri17 tion therapy interventions prevent or help prevent 

18 the onset or progression of more serious diseases, 

19 conditions, or disorders. 

20 (d) EFFECTIVE DATE.—The amendments made by 

21 this section shall apply to services furnished on or after 

22 January 1, 2008. 

Æ 

mstockstill on PROD1PC66 with BILLS
IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLORADO

Chief Judge Marcia S. Krieger

Civil Action No. 11-cv-01942-MSK-CBS

BARTON ARBUTHNOT, 

BLENDA ARBUTHNOT, 

BLAINE ARBUTHNOT, 

PAMELA ARBUTHNOT, 

LYNN CHUBBUCK, 

AMBER DECKER, 

JULIE DECKER, 

KAREN DIETRICH, 

MICHAEL DIETRICH, 

DOROTHY MASON, 

C.D., a minor, by and through her parents and next of friends, 

Plaintiffs, 

v. 

THE TOWN COUNCIL OF THE TOWN OF ORDWAY, COLORADO a municipal corporation of the

State of Colorado, 

THE CROWLEY COUNTY CHILD CARE CENTER, a Colorado non-profit corporation, d/b/a KIDS

CAMPUS, 

ANNETTE BOONE, an individual, 

ORVAL L. COLLINS a/k/a LAWRENCE O. COLLINS a/k/a LARRY COLLINS, individually, and in

his official capacity as Trustee of the Town of Ordway, Colorado, 

WILLIAM FERRITTO, individually, and in his official capacity as Marshal of the Town of Ordway,

Colorado, 

PETER MOORE, individually, and in his official capacity as Trustee of the Town or Ordway, Colorado,

KELLI JO RUSHER, in her official capacity as Mayor of the Town of Ordway, Colorado, 

DAWN SCHECK, an individual, 

CARRIE STEELE-COLLINS a/k/a CARRIE COLLINS a/k/a CARRIE ELEANOR STEELE,

individually, 

DOES 1-20, individuals 

Defendants. 

ORDER DISMISSING CLAIMS AGAINST DEFENDANT CARRIE STEELE-COLLINS

THIS MATTER comes before the Court on the Stipulation for Dismissal of Carrie

Steele-Collins With Prejudice (#112) filed February 7, 2013.

IT IS HEREBY ORDERED that the claims of all Plaintiffs, except Plaintiff C.D.,

Case 1:11-cv-01942-MSK-CBS Document 114 Filed 02/08/13 USDC Colorado Page 1 of 2
against Defendant Carrie Steele-Collins are hereby dismissed with prejudice. Each party shall

bear his, her or its own attorneys’ fees and costs except as otherwise agreed upon by the parties.

DATED this 8th day of February, 2013.

BY THE COURT:

Marcia S. Krieger

Chief United States District Judge

Case 1:11-cv-01942-MSK-CBS Document 114 Filed 02/08/13 USDC Colorado Page 2 of 2
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Small Business Administration

          - [License No. 09/79-0454]

Notice is hereby given that Emergence Capital Partners SBIC, L.P., 160 Bovet Road, Suite 300, San Mateo, CA 94402, a Federal Licensee under the Small Business Investment Act of 1958, as amended (“the Act”), in connection with the financing of a small concern, has sought an exemption under section 312 of the Act and section 107.730, Financings which Constitute Conflicts of Interest of the Small Business Administration (“SBA”) Rules and Regulations (13 CFR 107.730). Emergence Capital Partners SBIC, L.P. proposes to provide equity/debt security financing to PivotLink, Inc., 15325 SE 30th Place, Suite 300, Bellevue, WA 98007.

The financing is brought within the purview of § 107.730(a)(1) of the Regulations because Emergence Capital Partners, L.P. and Emergence Capital Associates, L.P., Associates of Emergence Capital Partners SBIC, L.P., own in the aggregate more than ten percent of PivotLink, Inc. Therefore this transaction is considered a financing of an Associate requiring prior SBA approval

Notice is hereby given that any interested person may submit written comments on the transaction, within fifteen days of the date of this publication, to the Associate Administrator for Investment, U.S. Small Business Administration, 409 Third Street, SW., Washington, DC 20416.

August 29, 2008.

A. Joseph Shepard,

Associate Administrator for Investment.

 [FR Doc. E8-23469 Filed 10-3-08; 8:45 am]

BILLING CODE 8025-01-P
1

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLORADO

Magistrate Judge David L. West

Criminal No. 11-PO-00136-DLW

UNITED STATES OF AMERICA,

Plaintiff,

vs.

1. WASH KMUSH BUCKSKIN,

Defendant.

 

MINUTE ORDER

 

ORDER ENTERED BY MAGISTRATE JUDGE DAVID L. WEST

IT IS HEREBY ORDERED that the Sentencing scheduled in this matter for December 21,

2011 at 4:00 p.m. is VACATED and RESCHEDULED for December 22, 2011 at 3:00 p.m.

DATED: December 19, 2011.

BY THE COURT:

s/David L. West 

United States Magistrate Judge

Case 1:11-po-00136-DW Document 13 Filed 12/19/11 USDC Colorado Page 1 of 1